BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States,
many eligible adults remain untreated. We projected the cost-effectiveness of treating
hypertension in U.S. adults according to the 2014 guidelines.
METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and
monitoring costs, costs...
BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States,
many eligible adults remain untreated. We projected the cost-effectiveness of treating
hypertension in U.S. adults according to the 2014 guidelines.
METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and
monitoring costs, costs...
BACKGROUND: On the basis of the 2014 guidelines for hypertension therapy in the United States,
many eligible adults remain untreated. We projected the cost-effectiveness of treating
hypertension in U.S. adults according to the 2014 guidelines.
METHODS: We used the Cardiovascular Disease Policy Model to simulate drug-treatment and
monitoring costs, costs...
OBJECTIVE: The associations of some risk factors with cardiovascular disease (CVD) are attenuated in
older age; whereas others appear robust. The present study aimed to compare CVD risk factors across
older age. METHODS: Participants (n = 4883) in the Cardiovascular Health Study free of prevalent CVD,
were stratified into three...
OBJECTIVE: The associations of some risk factors with cardiovascular disease (CVD) are attenuated in
older age; whereas others appear robust. The present study aimed to compare CVD risk factors across
older age. METHODS: Participants (n = 4883) in the Cardiovascular Health Study free of prevalent CVD,
were stratified into three...
